一项多中心研究分析维生素D缺乏及替代治疗与烧伤患者感染性结局的关系
这项7中心研究纳入烧伤患者,最终分析维生素D缺乏组234例(25OHD<20 ng/mL)与非缺乏组178例(25OHD≥20 ng/mL)。
研究设计与样本
- 7中心研究,纳入2016年1月至2019年8月收治的成年烧伤患者,初始纳入1147例。
- 排除后,维生素D缺乏组(25OHD<20 ng/mL)234例(56.8%),非缺乏组(25OHD≥20 ng/mL)178例。
- 采用广义线性混合模型控制中心效应、烧伤面积百分比、年龄和吸入性损伤。
主要发现
- 缺乏组感染性结局发生率52.1%,非缺乏组36.0%(p=0.002)。
- 缺乏组需肾脏替代治疗的急性肾损伤更常见(p=0.009),前28天无呼吸机天数更少(p<0.001),使用血管加压药更多(p=0.01)。
- 非缺乏组25OHD检测更早(p<0.001),男性比例更高(p=0.006),白人比例更高(p<0.001),体重指数更低(p=0.009),烧伤面积百分比更低(p=0.002),入院前服用25OHD补充剂比例更高(p<0.001)。
关键数值与推荐
- 缺乏定义:25OHD<20 ng/mL;非缺乏:25OHD≥20 ng/mL。
- 感染性结局:缺乏组52.1% vs 非缺乏组36.0%(p=0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitamin D (25OHD) deficiency is associated with poor outcomes in intensive care populations. The primary objective of this 7-center study was to determine if 25OHD deficiency is associated with infectious outcomes in adult burn patients. Generalized linear mixed modeling was used to control for center effect, percent total body surface area burn (% TBSA), age, and presence of inhalation injury. A total of 1147 patients were initially included (admitted January 2016 through August 2019). After exclusions, 234 (56.8%) in the deficient (25OHD<20 ng/mL) and 178 in the non-deficient group (25OHD ≥ 20 ng/mL) remained, surpassing a priori power requirements. The non-deficient group had their concentration drawn earlier (p < 0.001), were more likely to be male (p = 0.006), Caucasian (p < 0.001), have lower body mass index (p = 0.009), lower % TBSA (p = 0.002), and taking a 25OHD supplement prior to admission (p < 0.001). Deficient patients were more likely to have an infectious outcome (52.1% vs 36.0%, p = 0.002), acute kidney injury with renal replacement therapy (p = 0.009), less ventilator free days in the first 28 days (p < 0.001), and vasopressors (p = 0.01). After controlling for center, % TBSA, age, and inhalation injury the best model also included presence of deficiency (OR 2.425 [CI 1.206-4.876]), days until 25OHD supplement initiation (OR 1.139 [CI 1.035-1.252]), and choice of cholecalciferol over ergocalciferol (OR 2.112 [CI 1.151-3.877]). To the authors' knowledge, this is the first multicenter study to evaluate the relationship between 25OHD and infectious complications in burn patients.
引用
- Garner KM, Zavala S, Pape KO, et al. A multicenter study analyzing the association of vitamin D deficiency and replacement with infectious outcomes in patients with burn injuries. Burns. 2021. PMID: 34903417. doi:10.1016/j.burns.2021.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。